FDA Approved: EBANGA — Supplemental Application (Emergent Manufacturing Operations Baltimore, LLC)

View source ↗

Summary

FDA approved a supplemental application to authorize manufacturing operations for EBANGA (ansuvimab) by Emergent Manufacturing Operations Baltimore, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ebola Virus Disease

Drugs mentioned

• Ebanga (ansuvimab-zykl)

Snippet

SUPPL AP for EBANGA (ANSUVIMAB)